Isaly Samuel D

10% owner at PVLA; Director at Loxo Oncology, Inc.; 10% owner at Audentes Therapeutics, Inc., and 12 more

Sold, on record
$431M
Dollars the filings state
Form 4 sales
30
Latest Jan 3, 2018
Form 144 notices
0
Proposed sales
Companies
15
Filed as an executive or holder

Companies

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Sales by company

Shares sold, every Form 4 sale on record.

Timeline

  1. 1 Form 4 sale Relypsa IncPlan not stated
    Dec 23 2015

    Sold 500,000 shares at $27.18 ($13.6M)

    Isaly Samuel D, 10% owner

    Sold 6.3% of holdings ($215M position)7.4M shares leftFiling

  2. 2 Form 4 sale Relypsa IncUnusual
    Jul 25 +215 days

    Sold 4M shares at $32.00 ($129M)

    Isaly Samuel D, 10% owner

    Sold 54.6% of holdings ($237M position)3.4M shares leftFiling

  3. 3 Form 4 sale GKOSUnusual
    Mar 3 +221 days

    Sold 55,772 shares at $47.05 ($2.6M)

    Isaly Samuel D, Director

    Sold 73.6% of holdings ($3.6M position)20,044 shares leftFirst sale on recordFiling

  4. 4 Form 4 sale GKOSUnusual
    Sep 5 +186 days

    Sold 580,200 shares at $38.73 ($22.5M)

    Isaly Samuel D, Director

    Sold 98.7% of holdings ($22.8M position)7,895 shares leftFiling

  5. 5 Form 4 sale Roka BioScience, Inc.Unusual
    Sep 27 +22 days

    Sold 127,601 shares at $0.98 ($126k)

    Isaly Samuel D, 10% owner

    Sold 95.2% of holdings ($132k position)6,379 shares leftFirst sale on recordFiling

  6. 6 Form 4 sale Audentes Therapeutics, Inc.Plan not stated
    Sep 29 +2 days

    Sold 672,000 shares at $28.25 ($19M)

    Isaly Samuel D, 10% owner

    Sold 14% of holdings ($136M position)4.1M shares leftFirst sale on recordFiling

  7. 7 Form 4 sale Loxo Oncology, Inc.Plan not stated
    Nov 16 +48 days

    Sold 270,000 shares at $74.26 ($20.1M)

    Isaly Samuel D, Director

    Sold 15.6% of holdings ($128M position)1.5M shares leftFirst sale on recordFiling

  8. 8 Form 4 sale PVLAUnusual
    Jan 3 +48 days

    Sold 1.7M shares at $7.35 ($12.6M)

    Isaly Samuel D, 10% owner

    Sold 97.2% of holdings ($12.9M position)49,270 shares leftFirst sale on recordFiling

Every transaction

Loading transactions…

Sales and notices (30)

Form 144 notices and Form 4 sales by Isaly Samuel D
Source
Jan 3, 2018PVLA10% ownerForm 4 sale1.7M$12.6M97.2%UnusualSEC
Nov 16, 2017Loxo Oncology, Inc.DirectorForm 4 sale270,000$20.1M15.6%Plan not statedSEC
Sep 29, 2017Audentes Therapeutics, Inc.10% ownerForm 4 sale672,000$19M14.0%Plan not statedSEC
Sep 27, 2017Roka BioScience, Inc.10% ownerForm 4 sale127,601$126k95.2%UnusualSEC
Sep 5, 2017GKOSDirectorForm 4 sale580,200$22.5M98.7%UnusualSEC
Mar 3, 2017GKOSDirectorForm 4 sale55,772$2.6M73.6%UnusualSEC
Jul 25, 2016Relypsa Inc10% ownerForm 4 sale4M$129M54.6%UnusualSEC
Dec 23, 2015Relypsa Inc10% ownerForm 4 sale500,000$13.6M6.3%Plan not statedSEC
Oct 12, 2015Sientra, Inc.10% ownerForm 4 sale287,891$1.7M94.4%UnusualSEC
Oct 6, 2015Sientra, Inc.10% ownerForm 4 sale193,000$1.7M88.0%UnusualSEC
Oct 1, 2015Sientra, Inc.10% ownerForm 4 sale101,898$1M78.5%UnusualSEC
Sep 28, 2015Sientra, Inc.10% ownerForm 4 sale150,908$1.6M84.0%UnusualSEC
Mar 25, 2015INTERCEPT PHARMACEUTICALS INCDirectorForm 4 sale207,800$57M14.0%Plan not statedSEC
Aug 15, 2014Relypsa Inc10% ownerForm 4 sale990,000$26.1M10.0%Plan not statedSEC
Aug 14, 2014INTERCEPT PHARMACEUTICALS INCDirectorForm 4 sale60,000$18M3.6%Plan not statedSEC
Jul 1, 2014Mirati Therapeutics, Inc.10% ownerForm 4 sale107,332$2.3M8.4%Plan not statedSEC
Oct 15, 2013INTERCEPT PHARMACEUTICALS INCDirector, 10% ownerForm 4 sale376,585$23.5M17.5%Plan not statedSEC
Feb 13, 2013SUPN10% ownerForm 4 sale302,183$2.3M27.0%UnusualSEC
Jul 27, 2012AMRNDirectorForm 4 sale366,300$5.4M97.9%UnusualSEC
Jun 29, 2012Anthera Pharmaceuticals IncDirectorForm 4 sale1.3M$937k100.0%UnusualSEC
Mar 12, 2012PCRX10% ownerForm 4 sale100,100$1.1M3.9%Plan not statedSEC
Feb 3, 2012PCRX10% ownerForm 4 sale143,300$1.6M5.2%Plan not statedSEC
Nov 18, 2011Anthera Pharmaceuticals IncDirector, 10% ownerForm 4 sale52,000$351k1.8%Plan not statedSEC
Oct 31, 2011PCRX10% ownerForm 4 sale97,441$1M3.4%Plan not statedSEC
May 18, 2011Anthera Pharmaceuticals IncDirector, 10% ownerForm 4 sale181,334$1.5M5.5%Plan not statedSEC
May 2, 2011AMRNDirectorForm 4 sale132,900$2.1M88.5%UnusualSEC
Apr 20, 2011AMRNDirectorForm 4 sale3.8M$58.2M99.3%UnusualSEC
Dec 9, 2010NxStage Medical, Inc.DirectorForm 4 sale2,356$53k100.0%UnusualSEC
Sep 9, 2010NxStage Medical, Inc.Director, 10% ownerForm 4 sale55,900$933k1.3%Plan not statedSEC
May 16, 2006DOV PHARMACEUTICAL INCDirectorForm 4 sale817,771$2.7M76.0%UnusualSEC